Skip to main content
ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
22.40
-0.99 (-4.23%)
Mar 5, 2026, 4:00 PM EST - Market closed

ACADIA Pharmaceuticals Revenue by Product
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
NUPLAZID
680.09M 661.74M 650.67M 620.90M 590.42M 576.06M 560.67M 549.21M
NUPLAZID Growth
15.19% 14.87% 16.05% 13.05% 8.97% 9.17% 7.77% 6.17%
DAYBUE
391.42M 381.53M 370.00M 361.31M 338.78M 314.43M 253.10M - - - - - - - - - - - - -
DAYBUE Growth
15.54% 21.34% 46.19% - - - - - - - - - - - - - - - - -
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.